Hologic have entered into definitive agreements to acquire both Suros Surgical Systems and R2 Technology.
Suros Surgical Systems, a privately held manufacturer of minimally invasive surgical technologies focused on breast biopsy and tissue removal provide the ATEC® (Automated Tissue Excision and Collection) line of products for percutaneous, automatic vacuum assisted breast biopsy systems, ancillary breast biopsy devices and biopsy site markers. The purchase price for the transaction will be $240 million (subject to adjustment), plus a two-year earn out.
R2 Technology, a global expert in the field of computer-aided detection (CAD), will be purchased for $220 million (subject to adjustment) payable in shares of Hologic Common Stock. R2 Technology pioneered the use of CAD for mammography in 1998 when the ImageChecker system became the first CAD system approved by the FDA for screening mammography. The ImageChecker CAD system was also the first system approved for use with digital mammography.